(688278)"Xiamen Amoytop Biotech Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688278 · · 12 pages · Chinese
Summary by 6ix AI
The report includes a summary of major accounting data and financial indicators, as well as non-recurring profit and loss items. It also highlights the company's donations to various health initiatives during the reporting period. The financial statements included are unaudited and cover the first nine months of the year.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Xiamen Amoytop Biotech Co., Ltd. on 6ix
Earlier from Xiamen Amoytop Biotech
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Risk Warning Announcement on the Suitability Requirements for Convertible Bond Investors
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Progress in Repurchasing Shares
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Satisfaction of Vesting Conditions for the Second Vesting Period of the Initial Grant and the First Vesting Period of the Reserved Grant under the 2024 Restricted Share Incentive Plan
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2024 Restricted Share Incentive Plan
Later from Xiamen Amoytop Biotech
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Indicative Announcement on "Amoytop Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on External Donations
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Not Revising the Conversion Price of "Amoytop Convertible Bonds" Downward
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.
Follow Xiamen Amoytop Biotech